Associated Papers
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy.
Yang M et al.
Bmc Cancer, 2022
35272617 (PubMed )
Supplement: 12885_2022_9344_MOESM5_ESM.xlsx › 677_CRCs
Select a paper to view details